Pulmonary intravascular macrophages: Prime suspects as cellular mediators of porcine CARPA

European Journal of Nanomedicine

Volumn 7, Issue 1, 2015, Pages 27-36

  Csukás, Domokos ^a   Urbanics, Rudolf ^b   Wéber, György ^a   Rosivall, László ^a   Szebeni, János ^a,b,c  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b SeroScience Ltd   (Hungary)

^c UNIVERSITY OF MISKOLC   (Hungary)

Author keywords

adverse immune effects; anaphylatoxins; anaphylaxis; complement; hypersensitivity reactions; nanomedicines; pulmonary intravascular macrophages

Indexed keywords

ANTIGEN-ANTIBODY REACTIONS; BIOLOGICAL ORGANS; CELL ADHESION; CELLS; CHEMICAL ACTIVATION; MACROPHAGES; MAMMALS; MOBILE SECURITY; NANOPARTICLES; PATTERN RECOGNITION; PHYSIOLOGY;

ADVERSE IMMUNE EFFECTS; ANAPHYLATOXINS; ANAPHYLAXIS; COMPLEMENT; HYPERSENSITIVITY REACTION; INTRAVASCULAR; NANOMEDICINES;

CYTOLOGY;

ANAPHYLATOXIN; FC RECEPTOR; INDOMETACIN; INTEGRIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LEUKOTRIENE; NANOPARTICLE; THROMBOXANE A2; THROMBOXANE B2; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC REACTION; BLOOD FLOW; CAPILLARY WALL; CARDIOVASCULAR EFFECT; CELL ADHESION; CELL FUNCTION; CELL STRUCTURE; CELL SUBPOPULATION; CELL SURFACE; COMPLEMENT ACTIVATION RELATED PSEUDOALLERGY; KUPFFER CELL; LUNG ALVEOLUS MACROPHAGE; LUNG ARTERY PRESSURE; LUNG VASOCONSTRICTION; NONHUMAN; PATTERN RECOGNITION; PHAGOCYTOSIS; PROTEIN EXPRESSION; PULMONARY INTRAVASCULAR MACROPHAGE; REVIEW;

EID: 84924907634     PISSN: 16625986     EISSN: 1662596X     Source Type: Journal    
DOI: 10.1515/ejnm-2015-0008     Document Type: Review

References (73)

1. Szebeni J. Complement activation-related pseudoallergy: a new class of drug-induced immune toxicity. Toxicology 2005;216: 106-21.
2. Szebeni J. Complement activation-related pseudoallergy: a stress reaction in blood triggered by nanomedicines and biologicals. Mol Immunol 2014;61:163-73.
3. Szebeni J, Bedocs P, Csukas D, Rosivall L, Bunger R, Urbanics R. A porcine model of complement-mediated infusion reactions to drug carrier nanosystems and other medicines. Adv Drug Deliver Rev 2012;64:1706-16.
4. Szebeni J, Fontana JL, Wassef NM, Mongan PD, Morse DS, Dobbins DE, et al. Hemodynamic changes induced by liposomes and liposome-encapsulated hemoglobin in pigs: a model for pseudoallergic cardiopulmonary reactions to liposomes. Role of complement and inhibition by soluble CR1 and anti-C5a antibody. Circulation 1999;99:2302-9.
5. Szebeni J, Baranyi L, Savay S, Bodo M, Morse DS, Basta M, et al. Liposome-induced pulmonary hypertension: properties and mechanism of a complement-mediated pseudoallergic reaction. Am J Physiol-Heart C 2000;279:H1319-28.
6. Szebeni J, Baranyi L, Savay S, Bodo M, Milosevits J, Alving CR, et al. Complement activation-related cardiac anaphylaxis in pigs: role of C5a anaphylatoxin and adenosine in liposomeinduced abnormalities in ECG and heart function. Am J Physiol-Heart C 2006;290:H1050-8.
7. Szebeni J, Bedcs P, Urbanics R, Bunger R, Rosivall L, Tóth M, et al. Prevention of infusion reactions to PEGylated liposomal doxorubicin via tachyphylaxis induction by placebo vesicles: a porcine model. J Contr Rel 2012;160:382-7.
8. Szebeni J, Bedcs P, Rozsnyay Z, Weiszhár Z, Urbanics R, Rosivall L, et al. Liposome-induced complement activation and related cardiopulmonary distress in pigs: factors promoting reactogenicity of Doxil and AmBisome. Nanomedicine NBM 2012;8:176-84.
9. Brain JD, Molina RM, DeCamp MM, Warner AE. Pulmonary intravascular macrophages: their contribution to the mononuclear phagocyte system in 13 species. Am J Physiol Lung Cell Mol Physiol 1999;276:146-54.
10. Winkler GC, Cheville NF. Postnatal colonization of porcine lung capillaries by intravascular macrophages: an ultrastructural, morphometric analysis. Microvasc Res 1987;33:224-32.
11. Longworth KE, Albertine KH, Staub NC. Ultrastructural quantification of pulmonary intravascular macrophages in newborn and 2-week-old lambs. Anat Rec 1996;246:238-44.
12. Chang SW, Ohara N. Chronic biliary obstruction induces pulmonary intravascular phagocytosis and endotoxin sensitivity in rats. J Clin Invest 1994;94:2009-19.
13. Singh B, Doane KJ, Niehaus GD. Ultrastructural and cytochemical evaluation of sepsis-induced changes in the rat pulmonary intravascular mononuclear phagocytes. J Anat 1998;192 (Pt 1):13-23.
14. Warner AE, Brain JD. The cell biology and pathogenic role of pulmonary intravascular macrophages. Am J Physiol 1990;258 (2 Pt 1):L1-12.
15. Staub NC. Pulmonary intravascular macrophages. Annu Rev Physiol 1994;56:47-67.
16. Miot-Noirault E, Faure L, Guichard Y, Montharu J, Le Pape A. Scintigraphic in vivo assessment of the development of pulmonary intravascular macrophages in liver disease: experimental study in rats with biliary cirrhosis. Chest 2001;120:941-7.
17. Dzsi L, Fülöp T, Mészáros T, Szénási G, Urbanics R, Vázsonyi C, et al. Features of complement activation-related pseudoallergy to liposomes with different surface charge and pegylation: comparison of the porcine and rat responses. J Control Release 2014;165:2-10.
18. Warner AE, Barry BE, Brain JD. Pulmonary intravascular macrophages in sheep. Morphology and function of a novel constituent of the mononuclear phagocyte system. Lab Invest J Tech Method Pathol 1986;55:276-88.
19. Winkler GC. Pulmonary intravascular macrophages in domestic animal species: review of structural and functional properties. Am J Anat 1988;181:217-34.
20. Parbhakar OP, Duke T, Townsend HG, Singh B. Immunophenotypic characterization and depletion of pulmonary intravascular macrophages of horses. Vet Res 2004;35:39-51.
21. Morton D, Bertram TA. Isolation and preliminary in vitro characterization of the porcine pulmonary intravascular macrophage. J Leukocyte Biol 1988;43:403-10.
22. Atwal OS, Singh B, Staempfli H, Minhas K. Presence of pulmonary intravascular macrophages in the equine lung: some structurofunctional properties. Anat Rec 1992;234:530-40.
23. Singh B, Ireland WP, Minhas K, Atwal OS. Surface coat of sheep pulmonary intravascular macrophages: reconstitution, and implication of a glycosyl-phosphatidylinositol anchor. Anat Rec 1995;243:466-78.
24. Atwal OS, Minhas KJ, Williams CS. Ultrastructural response of pulmonary intravascular macrophages to exogenous oestrogen in the bovine lung: translocation of the surface-coat and enhanced cell membrane plasticity and angiogenesis. J Anat 2001;198(Pt 5):611-24.
25. Schneberger D, Aharonson-Raz K, Singh B. Pulmonary intravascular macrophages and lung health: what are we missing? Am J Physiol Lung Cell Mol Physiol 2012;302:L498-503.
26. Singh B, Atwal OS. Ultrastructural and immunocytochemical study of the pulmonary intravascular macrophages of Escherichia coli lipopolysaccharide-treated sheep. Anat Rec 1997;247:214-24.
27. Brain JD. Mechanisms, measurement, and significance of lung macrophage function. Environ Health Persp 1992;97:5-10.
28. DeCamp MM, Warner AE, Molina RM, Brain JD. Hepatic versus pulmonary uptake of particles injected into the portal circulation in sheep. Endotoxin escapes hepatic clearance causing pulmonary inflammation. Am Rev Respir Dis 1992;146:224-31.
29. Longworth KE. The comparative biology of pulmonary intravascular macrophages. Front BioSci J Virtual Libr 1997;2:d232-41.
30. Warner AE, DeCamp MM, Jr., Molina RM, Brain JD. Pulmonary removal of circulating endotoxin results in acute lung injury in sheep. Lab Inves J Tech Method Pathol 1988;59:219-30.
31. Staub NC. Pulmonary intravascular macrophages. Chest 1988;93(3 Suppl):84s-5s.
32. Singh B, Minhas KJ, Atwal OS. Ultracytochemical study of multiple dose effect of monastral blue uptake by equine pulmonary intravascular macrophages (PIMs). J Submicr Cytol Path 1994;26:235-43.
33. Leifsson PS, Basse A, Jensen HE, Bloch B, Aalbaek B. Pulmonary intravascular macrophages in the pathogenesis of bovine pulmonary lesions caused by Actinomyces pyogenes. J Compar Pathol 1995;112:197-206.
34. Sierra MA, Carrasco L, Gomez-Villamandos JC, Martin de las Mulas J, Mendez A, Jover A. Pulmonary intravascular macrophages in lungs of pigs inoculated with African swine fever virus of differing virulence. J Compar Pathol 1990;102:323-34.
35. Carrasco L, Ruiz-Villamor E, Gómez-Villamandos JC, Salguero FJ, Bautista MJ, Maciá M, et al. Classical swine fever: morphological and morphometrical study of pulmonary intravascular macrophages. J Comp Path 2001;125:1-7.
36. Aharonson-Raz K, Singh B. Pulmonary intravascular macrophages and endotoxin-induced pulmonary pathophysiology in horses. Can J Vet Res 2010;74:45-9.
37. Humphries MJ. Integrin structure. Biochem Soc Trans 2000;28:311-39.
38. Carrasco L, Nunez A, Salguero FJ, Diaz San Segundo F, Sanchez-Cordon P, Gomez-Villamandos JC, et al. African swine fever: Expression of interleukin-1 alpha and tumour necrosis factor-alpha by pulmonary intravascular macrophages. J Comparat Pathol 2002;126:194-201.
39. Basu S, Fenton MJ. Toll-like receptors: function and roles in lung disease. Am J Physiol Lung Cell Mol Physiol 2004;286:L887-92.
40. Wassef A, Janardhan K, Pearce JW, Singh B. Toll-like receptor 4 in normal and inflamed lungs and other organs of pig, dog and cattle. Histol Histopathol 2004;19:1201-8.
41. Ezquerra A, Revilla C, Alvarez B, Perez C, Alonso F, Dominguez J. Porcine myelomonocytic markers and cell populations. Dev Comp Immunol 2009;33:284-98.
42. Swanson JA, Hoppe AD. The coordination of signaling during Fc receptor-mediated phagocytosis. J Leukocyte Biol 2004;76:1093-103.
43. Lohmann-Matthes ML, Steinmuller C, Franke-Ullmann G. Pulmonary macrophages. Eur Respir J 1994;7:1678-89.
44. Jacobson AC, Weis JJ, Weis JH. Complement receptors 1 and 2 influence the immune environment in a B cell receptor-independent manner. J Immunol 2008;180:5057-66.
45. Henson PM, McCarthy K, Larsen GL, Webster RO, Giclas PC, Dreisin RB, et al. Complement fragments, alveolar macrophages, and alveolitis. Am J Pathol 1979;97:93-110.
46. McCarthy K, Henson PM. Induction of lysosomal enzyme secretion by alveolar macrophages in response to the purified complement fragments C5a and C5a des-arg. J Immunol 1979;123:2511-7.
47. Larsen GL, McCarthy K, Webster RO, Henson J, Henson PM. A differential effect of C5a and C5a des Arg in the induction of pulmonary inflammation. Am J Pathol 1980;100:179-92.
48. Fine R, Shaw JO, Rogers WR. Effects of C5a on baboon alveolar macrophage migration. Am Rev Respir Dis 1981;123:110-4.
49. Cantu E, Gaca JG, Palestrant D, Baig K, Lukes DJ, Gibson SE, et al. Depletion of pulmonary intravascular macrophages prevents hyperacute pulmonary xenograft dysfunction. Transplantation 2006;81:1157-64.
50. Bertram TA, Overby LH, Danilowicz R, Eling TE, Brody AR. Pulmonary intravascular macrophages metabolize arachidonic acid in vitro. Comparison with alveolar macrophages. Am Rev Respir Dis 1988;138:936-44.
51. Siore AM, Parker RE, Stecenko AA, Cuppels C, McKean M, Christman BW, et al. Endotoxin-induced acute lung injury requires interaction with the liver. Am J Physiol Lung Cell Mol Physiol 2005;289:L769-76.
52. Bertram TA, Overby LH, Danilowicz R, Eling TE, Brody AR. Pulmonary intravascular macrophages produce prostaglandins and leukotrienes in vitro. Chest 1988;93(3 Suppl):82s-4s.
53. Parbhakar OP, Duke T, Townsend HG, Singh B. Depletion of pulmonary intravascular macrophages partially inhibits lipopolysaccharide-induced lung inflammation in horses. Vet Res 2005;36:557-69.
54. Duke-Novakovski T, Singh-Suri S, Kajikawa O, Caldwell S, Charavaryamath C, Singh B. Immuno-phenotypic and functional characterization of rabbit pulmonary intravascular macrophages. Cell Tissue Res 2013;351:149-60.
55. Singh B, Pearce JW, Gamage LN, Janardhan K, Caldwell S. Depletion of pulmonary intravascular macrophages inhibits acute lung inflammation. Am J Physiol Lung Cell Mol Physiol 2004;286:L363-72.
56. Thenappan T, Goel A, Marsboom G, Fang YH, Toth PT, Zhang HJ, et al. A central role for CD68(+) macrophages in hepatopulmonary syndrome. Reversal by macrophage depletion. Am J Respir Crit Care Med 2011;183:1080-91.
57. Bhatia M, Moochhala S. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol 2004;202:145-56.
58. Warner AE, Molina RM, Brain JD. Uptake of bloodborne bacteria by pulmonary intravascular macrophages and consequent inflammatory responses in sheep. Am Rev Respir Dis 1987;136:683-90.
59. Miyamoto K, Schultz E, Heath T, Mitchel MD, Albertine KH, Staub NC. Pulmonary intravascular macrophages and hemodynamic effects of liposomes in sheep. J Appl Physiol 1988;64:1143-50.
60. Staub NC, Sr., Longworth KE, Serikov V, Jerome EH, Elsasser T. Detergent inhibits 70-90% of responses to intravenous endotoxin in awake sheep. J Appl Physiol (1985) 2001;90:1788-97.
61. Mizgerd JP, Molina RM, Stearns RC, Brain JD, Warner AE. Gadolinium induces macrophage apoptosis. J Leukocyte Biol 1996;59:189-95.
62. Singh B, de la Concha-Bermejillo A. Gadolinium chloride removes pulmonary intravascular macrophages and curtails the degree of ovine lentivirus-induced lymphoid interstitial pneumonia. Int J Exp pathol 1998;79:151-62.
63. Gaca JG, Palestrant D, Lukes DJ, Olausson M, Parker W, Davis RD, Jr. Prevention of acute lung injury in swine: depletion of pulmonary intravascular macrophages using liposomal clodronate. J Surg Res 2003;112:19-25.
64. Holt PG, Degebrodt A, Venaille T, O'Leary C, Krska K, Flexman J, et al. Preparation of interstitial lung cells by enzymatic digestion of tissue slices: preliminary characterization by morphology and performance in functional assays. Immunol 1985;54:139-47.
65. Chitko-McKown CG, Chapes SK, Brown RE, Phillips RM, McKown RD, Blecha F. Porcine alveolar and pulmonary intravascular macrophages: comparison of immune functions. J Leukocyte Biol 1991;50:364-72.
66. Sakai H, Suzuki Y, Sou K, Kano M. Cardiopulmonary hemodynamic responses to the small injection of hemoglobin vesicles (artificial oxygen carriers) in miniature pigs. J BioMed Mater Res Part A. 2012;100:2668-77.
67. Sone Y, Serikov VB, Staub NC, Sr. Intravascular macrophage depletion attenuates endotoxin lung injury in anesthetized sheep. J Appl Physiol (1985) 1999;87:1354-9.
68. Puchner TC, Kugathasan S, Kelly KJ, Binion DG. Successful desensitization and therapeutic use of infliximab in adult and pediatric Crohn's disease patients with prior anaphylactic reaction. Inflamm Bowel Dis 2001;7:34-7.
69. Duburque C, Lelong J, Iacob R, Seddik M, Desreumaux P, Fournier C, et al. Successful induction of tolerance to infliximab in patients with Crohn's disease and prior severe infusion reactions. Aliment Pharmacol Ther 2006;24:851-8.
70. Castells MC. Hypersensitivity to antineoplastic agents. CurrPharmDes 2008;14:2892-901.
71. Castells MC, Tennant NM, Sloane DE, Hsu FI, Barrett NA, Hong DI, et al. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases. J Allergy Clin Immunol 2008;122:574-80.
72. Gabizon AA, Muggia FM. Initial clinical evaluation of pegylated liposomal doxorubicin in solid tumors. In: Woodle MC, G. S, editors. Long-circulating liposomes: old drugs, new therapeutics. Austin, TX: Landes Bioscience, 1998:155-74.
73. Klingensmith WC, 3rd, Yang SL, Wagner HN, Jr. Lung uptake of Tc-99m sulfur colloid in liver and spleen imaging. J Nucl Med Official Publ Soc Nucl Med 1978;19:31-5.